Deutsch English Français

Contact

EP1282365

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1282365

EP1282365 - PREPARATION FOR THE PREVENTION AND/OR TREATMENT OF VASCULAR DISORDERS [Right-click to bookmark this link]
Status	Patent revoked Status updated on 15.01.2016 Database last updated on 20.12.2024
Most recent event Tooltip	29.04.2016	Lapse of the patent in a contracting state	published on 01.06.2016 [2016/22]
Applicant(s)	For all designated states N.V. Nutricia Postbus 1 2700 MA Zoetermeer / NL
	[2007/52]
Former [2003/07]	For all designated states N.V. Nutricia Postbus 1 2700 MA Zoetermeer / NL
Inventor(s)	01 / KILIAAN, Amanda, Johanne Harnjesweg 89 NL-6706 AS Wageningen / NL
	02 / HAGEMAN, Robert, Johan, Joseph Hamsterlaan 12 NL-6705 CT Wageningen / NL
	[2003/07]
Representative(s)	Nederlandsch Octrooibureau P.O. Box 29720 2502 LS The Hague / NL
	[2013/28]
Former [2008/22]	van Westenbrugge, Andries, et al Postbus 29720 2502 LS Den Haag / NL
Former [2003/16]	van Westenbrugge, Andries, et al Nederlandsch Octrooibureau P.O. Box 29720 2502 LS The Hague / NL
Former [2003/07]	Jorritsma, Ruurd, et al Nederlandsch Octrooibureau Scheveningseweg 82 P.O. Box 29720 2502 LS Den Haag / NL
Application number, filing date	01928256.5	08.05.2001
	[2003/07]
	WO2001NL00347
Priority number, date	US20000566386	08.05.2000 Original published format: US 566386
	US20000703798	02.11.2000 Original published format: US 703798
	[2003/07]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO0184961
	Date:	15.11.2001
	Language:	EN
	[2001/46]
	Type:	A2 Application without search report
	No.:	EP1282365
	Date:	12.02.2003
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 15.11.2001 takes the place of the publication of the European patent application.
	[2003/07]
	Type:	B1 Patent specification
	No.:	EP1282365
	Date:	26.12.2007
	Language:	EN
	[2007/52]
Search report(s)	International search report - published on:	EP	15.08.2002
Classification	IPC:	A23L1/30, A23L1/302, A23J7/00, A23L1/304	[2003/07]
	CPC:	A61K31/685 (EP,US); A23L33/105 (EP,US); A23L33/115 (EP,US); A23L33/15 (EP,US); A23L33/16 (EP,US); A61K31/14 (US); (+) A61K31/194 (US); A61K31/20 (EP,US); A61K31/202 (US); A61K31/205 (US); A61K31/355 (US); A61K31/4415 (US); A61K31/519 (US); A61K31/683 (US); A61K33/30 (EP,US); A61K33/34 (EP,US); A61K36/16 (EP,US); A61K45/06 (EP,US); A61P25/16 (EP); A61P25/28 (EP); A61P3/06 (EP); A61P9/00 (EP); A61P9/10 (EP); A61P9/12 (EP); A23V2002/00 (EP,US) (-)
	C-Set:	A61K31/20, A61K2300/00 (US,EP); A61K31/685, A61K2300/00 (US,EP); A61K33/30, A61K2300/00 (US,EP); A61K33/34, A61K2300/00 (US,EP); (+) A61K36/16, A61K2300/00 (EP,US); A23V2002/00, A23V2250/1842, A23V2250/7052, A23V2250/706, A23V2250/161, A23V2250/1642, A23V2250/032 (EP,US); A23V2002/00, A23V2250/1846, A23V2250/1852, A23V2250/1848, A23V2250/7052, A23V2250/706, A23V2250/156, A23V2250/032 (EP,US); A23V2002/00, A23V2250/5114, A23V2250/032, A23V2250/161, A23V2250/1642, A23V2250/704, A23V2250/716, A23V2250/1842 (EP,US) (-)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/07]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	ZUBEREITUNG ZUR VORBEUGUNG UND BEHANDLUNG VON GEFÄßKRANKHEITEN	[2007/35]
	English:	PREPARATION FOR THE PREVENTION AND/OR TREATMENT OF VASCULAR DISORDERS	[2003/07]
	French:	PREPARATION POUR LA PREVENTION ET/OU LE TRAITEMENT DE TROUBLES VASCULAIRES	[2003/07]
	Former [2003/07]	PRÄPARATION ZUR PRÄVENTION UND BEHANDLUNG VON VASKULÄREN KRANKHEITEN
Entry into regional phase	09.12.2002	National basic fee paid
	09.12.2002	Designation fee(s) paid
	09.12.2002	Examination fee paid
Examination procedure	06.12.2001	Request for preliminary examination filed International Preliminary Examining Authority: EP
	09.12.2002	Examination requested [2003/07]
	10.05.2005	Despatch of a communication from the examining division (Time limit: M04)
	01.09.2005	Reply to a communication from the examining division
	20.02.2006	Despatch of a communication from the examining division (Time limit: M02)
	27.03.2006	Reply to a communication from the examining division
	12.01.2007	Despatch of a communication from the examining division (Time limit: M04)
	23.02.2007	Reply to a communication from the examining division
	07.09.2007	Communication of intention to grant the patent
	08.10.2007	Fee for grant paid
	08.10.2007	Fee for publishing/printing paid
Divisional application(s)	EP07120681.7 / EP1911442
	EP09156648.9 / EP2070519
	EP10186257.1 / EP2292210
	EP10186282.9 / EP2316426
Opposition(s)	Opponent(s)	01 17.09.2008 27.10.2008 ADMISSIBLE Fresenius Kabi Deutschland GmbH Else-Kröner-Stasse 1 61352 Bad-Homburg v.d.H. / DE
		02 22.09.2008 27.10.2008 ADMISSIBLE UNILEVER N.V. / UNILEVER PLC Weena 455/Unilever House, Blackfriars 3013 AL Rotterdam/London EC4P 4BQ / NL Opponent's representative Corsten, Michael Allan, et al, et al Unilever N.V. Unilever Patent Group Bronland 14 6708 WH Wageningen / NL
		[N/P]
	Former [2013/25]
	Opponent(s)	01 17.09.2008 27.10.2008 ADMISSIBLE Fresenius Kabi Deutschland GmbH Else-Kröner-Stasse 1 61352 Bad-Homburg v.d.H. / DE
		02 22.09.2008 27.10.2008 ADMISSIBLE UNILEVER N.V. / UNILEVER PLC Weena 455/Unilever House, Blackfriars 3013 AL Rotterdam/London EC4P 4BQ / NL Opponent's representative Corsten, Michael Allan, et al, et al Unilever Patent Group Olivier van Noortlaan 120 3133 AT Vlaardingen / NL
	Former [2010/11]
	Opponent(s)	01 17.09.2008 27.10.2008 ADMISSIBLE Fresenius Kabi Deutschland GmbH Else-Kröner-Stasse 1 61352 Bad-Homburg v.d.H. / DE Opponent's representative Richly, Erik, et al, et al Fresenius Kabi Deutschland GmbH Patent Department Else-Kröner-Strasse 1 61352 Bad Homburg / DE
		02 22.09.2008 27.10.2008 ADMISSIBLE UNILEVER N.V. / UNILEVER PLC Weena 455/Unilever House, Blackfriars 3013 AL Rotterdam/London EC4P 4BQ / NL Opponent's representative Corsten, Michael Allan, et al, et al Unilever Patent Group Olivier van Noortlaan 120 3133 AT Vlaardingen / NL
	Former [2010/09]
	Opponent(s)	01 17.09.2008 27.10.2008 ADMISSIBLE Fresenius Kabi Deutschland GmbH Else-Kröner-Stasse 1 61352 Bad-Homburg v.d.H. / DE Opponent's representative Weiß, Stefan, et al, et al Fresenius Medical Care AG & Co. KGaA Bereich Patente Pfingstweide 53 D-61169 Friedberg / DE
		02 22.09.2008 27.10.2008 ADMISSIBLE UNILEVER N.V. / UNILEVER PLC Weena 455/Unilever House, Blackfriars 3013 AL Rotterdam/London EC4P 4BQ / NL Opponent's representative Corsten, Michael Allan, et al, et al Unilever Patent Group Olivier van Noortlaan 120 3133 AT Vlaardingen / NL
	Former [2008/45]
	Opponent(s)	01 17.09.2008 Fresenius Kabi Deutschland GmbH Else-Kröner-Stasse 1 61352 Bad-Homburg v.d.H. / DE Opponent's representative Weiß, Stefan, et al, et al Fresenius Medical Care AG & Co. KGaA Bereich Patente Pfingstweide 53 D-61169 Friedberg / DE
		02 22.09.2008 UNILEVER N.V. / UNILEVER PLC Weena 455/Unilever House, Blackfriars 3013 AL Rotterdam/London EC4P 4BQ / NL Opponent's representative Joppe, Hermina Laura Petronella, et al, et al Unilever Patent Group P.O. Box 137 3130 AC Vlaardingen / NL
	Former [2008/44]
	Opponent(s)	01 17.09.2008 Fresenius Kabi Deutschland GmbH Else-Kröner-Stasse 1 61352 Bad-Homburg v.d.H. / DE Opponent's representative Weiß, Stefan, et al, et al Fresenius Medical Care AG & Co. KGaA Bereich Patente Pfingstweide 53 D-61169 Friedberg / DE
	31.10.2008	Invitation to proprietor to file observations on the notice of opposition
	08.05.2009	Reply of patent proprietor to notice(s) of opposition
	07.12.2011	Date of oral proceedings
	25.01.2012	Despatch of minutes of oral proceedings
	25.01.2012	Despatch of communication that the patent will be revoked
	12.11.2015	Legal effect of revocation of patent [2016/07]
Appeal following opposition	20.03.2012	Appeal received No. T0624/12
	04.06.2012	Statement of grounds filed
	12.11.2015	Result of appeal procedure: appeal of the proprietor withdrawn
Fees paid	Renewal fee
	07.04.2003	Renewal fee patent year 03
	09.03.2004	Renewal fee patent year 04
	31.03.2005	Renewal fee patent year 05
	28.04.2006	Renewal fee patent year 06
	30.03.2007	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CH	26.12.2007
	LI	26.12.2007
	[2016/22]
Cited in	International search	[XA]WO9319624 (ABBOTT LAB [US]) [X] 1,2,4,5,7-11,15,16,18 * claims 1-10; tables 2-8 * * page 8, paragraphs 3,4 * [A] 3,6,12-14,17;
		[XA]WO9427628 (ABBOTT LAB [US]) [X] 1,2,4,7-11,18 * claims 1,2,5; tables 3,4,6 * * page 7, paragraph 1 * [A] 3,5,6,12-17;
		[X]EP0652012 (NAITO ALBERT [US]) [X] 1,4,7,8,10,11,15,17,18* example 16; claim 3 *;
		[XA]EP0721742 (CLINTEC NUTRITION CO [US]) [X] 1,4,7,8,10,11,18 * claims 1,3 * * page 2, lines 36-43 * * page 3, lines 1-3 * * page 4, lines 4-9,15-55 * * page 5, lines 14-18 * [A] 2,3,5,6,9,12-17;
		[XA]WO9739749 (ABBOTT LAB [US]) [X] 1,2,4,5,7-11,18 * examples 1,3,4; claims 1,4,6; tables 2,3,6,7 * * page 10, lines 4-19 * [A] 3,6,12-17;
		[X]FR2773484 (MOREAU PIERRE [FR]) [X] 1,2,4,5,10-12,15,16,18 * example 4; claims 1,6-8,10,12,13,18 * * page 4, lines 37-39 * * page 5, lines 26-37 *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p